当前位置:首页 - 行情中心 - 太龙药业(600222) - 财务分析 - 现金流量表

太龙药业

(600222)

  

流通市值:49.24亿  总市值:49.24亿
流通股本:5.74亿   总股本:5.74亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,197,876,027.92823,784,786.09414,804,628.031,948,869,046.91
  收到的税费返还---1,579,837.62
  收到其他与经营活动有关的现金8,407,148.595,417,805.342,430,749.1319,102,724.36
  经营活动现金流入小计1,206,283,176.51829,202,591.43417,235,377.161,969,551,608.89
  购买商品、接受劳务支付的现金927,180,790.99696,218,549.63262,741,184.621,379,341,573.31
  支付给职工以及为职工支付的现金229,968,331158,727,411.3583,831,382.91344,820,358.14
  支付的各项税费52,785,570.5432,850,227.1120,398,994.9260,608,121.09
  支付其他与经营活动有关的现金85,337,525.1653,088,037.4439,313,365.14224,367,275.11
  经营活动现金流出小计1,295,272,217.69940,884,225.53406,284,927.592,009,137,327.65
  经营活动产生的现金流量净额-88,989,041.18-111,681,634.110,950,449.57-39,585,718.76
二、投资活动产生的现金流量:
  收回投资收到的现金124,219,785.66122,019,785.6683,954,415.01529,307,835.29
  取得投资收益收到的现金22,993,898.0422,992,730.6418,070,053.552,630,103.96
  处置固定资产、无形资产和其他长期资产收回的现金净额60,42660,42683,300167,181
  处置子公司及其他营业单位收到的现金净额1,582,224---
  收到的其他与投资活动有关的现金00-3,249,654.21
  投资活动现金流入小计148,856,333.7145,072,942.3102,107,768.56535,354,774.46
  购建固定资产、无形资产和其他长期资产支付的现金12,061,211.876,611,350.794,412,158.4937,231,519.19
  投资支付的现金47,750,00047,750,0008,250,000479,872,300
  投资活动现金流出小计59,811,211.8754,361,350.7912,662,158.49517,103,819.19
  投资活动产生的现金流量净额89,045,121.8390,711,591.5189,445,610.0718,250,955.27
三、筹资活动产生的现金流量:
  取得借款收到的现金830,018,450.51702,635,766.27294,709,780.95833,494,585.88
  收到其他与筹资活动有关的现金760,975,349.61314,900,000129,900,000534,162,654.09
  筹资活动现金流入小计1,590,993,800.121,017,535,766.27424,609,780.951,367,657,239.97
  偿还债务支付的现金880,682,009.99553,540,971.74242,479,797.52552,411,298.76
  分配股利、利润或偿付利息支付的现金39,608,231.0628,338,146.3615,559,948.3169,068,473.64
  支付其他与筹资活动有关的现金495,939,310.12340,096,080.1743,060,953.58755,953,313.92
  筹资活动现金流出小计1,416,229,551.17921,975,198.27301,100,699.411,377,433,086.32
  筹资活动产生的现金流量净额174,764,248.9595,560,568123,509,081.54-9,775,846.35
五、现金及现金等价物净增加额174,820,329.674,590,525.41223,905,141.18-31,110,609.84
  加:期初现金及现金等价物余额143,892,905.85143,892,905.85143,892,905.85175,003,515.69
  期末现金及现金等价物余额318,713,235.45218,483,431.26367,798,047.03143,892,905.85
补充资料:
  净利润-22,601,677.95-53,495,468.69
  资产减值准备--9,807,663.33-7,323,009.67
  固定资产和投资性房地产折旧-23,959,380.24-46,204,926.79
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,959,380.24-46,204,926.79
  无形资产摊销-2,905,223.24-5,584,475.72
  长期待摊费用摊销-4,469,147.1-8,377,537.62
  处置固定资产、无形资产和其他长期资产的损失-0--129,923.84
  固定资产报废损失-73,320.16--2,544.69
  公允价值变动损失--1,451,657.5--7,937,549.17
  财务费用-27,156,765.34-57,515,697.14
  投资损失-596,645.68--2,736,772.52
  递延所得税--146,132.52--20,075,862.08
  其中:递延所得税资产减少--2,388,444.72--18,966,120.63
    递延所得税负债增加-2,242,312.2--1,109,741.45
  存货的减少--108,237,768.17-91,063,826.47
  经营性应收项目的减少--2,248,894.6--91,315,475.51
  经营性应付项目的增加--81,857,859.17--196,555,964.71
  现金的期末余额-218,483,431.26-143,892,905.85
  减:现金的期初余额-143,892,905.85-175,003,515.69
  现金及现金等价物的净增加额-74,590,525.41--31,110,609.84
公告日期2025-10-302025-08-272025-04-302025-04-09
审计意见(境内)标准无保留意见
TOP↑